Goeldi's monkey (Callimico 
Introduction
Goeldi's monkey (Callimico (Wolfheim, 1983 ). Goeldi's monkey is rare and, indeed, is officially recognized as an endangered species. Captive populations of Goeldi's monkey have been established and are coordinated and managed at an international level (Warneke, 1992) . Studies of this species in captivity have been concerned with reproductive behaviour (Beck et al, 1982; Carroll, 1982 Carroll, , 1985 and various aspects of reproductive endocrinology. The data available on female reproductive endocrinology of Goeldi's monkey constitute descriptions of the ovarian cycle and of pregnancy based on the metabolites of reproductive steroid and peptide hormones in urine or faeces (Carroll et al, 1989 (Carroll et al, , 1990 Christen et al, 1989; (Jurke et al, in press); 0.5-1.0 ml of urine was trans¬ ferred into a cryotube and stored at -25°C before analysis. The female was then caught and transferred to a restraint appar¬ atus (Hearn, 1977) 20 ml, were used to extract four aliquots of each sample (plasma: 20 µ , urine 2 µ , made up to 50 µ with Pas-Gel buffer-0.04% NaH2P04, 0.13% Na2HP04-2H20, 0.8% NaCl, 0.1% NaN3, 0.1% gelatine) with diethyl ether to remove any unconjugated oestrone and oestradiol. The aqueous phase was then hydrolysed for 10 h at 37°C with 300 Fishman-U of puri¬ fied ß-glucuronidase (Fluka (Sigma) Chemie AG, Buchs) con¬ tained in 50 µ Pas-Gel buffer (0.1 mol 1, pH 7.0). After extraction of the oestrogens cleaved from glucuronide(s), the aqueous phase was hydrolysed for 20 h at 37°C with 20 µ of sulfatase (Fluka (Sigma)), added in 200 µ phosphate hydrolysis buffer (0.25 mol l-1, pH 5.0); the hydrolysate was extracted to remove the oestrogens cleaved from sulfate(s). The remaining aqueous phase was made up to 600 µ by the addition of 300 µ phosphate hydrolysis buffer; it was acidified using sulfuric acid (50 µ , 0.03 mol l"1), sodium chloride (100 µ , 6.0 mol l"1) was added, and the remaining oestrogen conjugates were solvolysed using ethyl acetate (4.0 ml) for 20 h at 40°C (Hawkins and Oakey, 1974 Fig. 1 ).
Plasma and urinary oestrone-3-conjugates. Oestrone-3-conjugates were estimated directly in plasma and urine samples using a non-specific radioimmunoassay (Eastman et al, 1984 (1987) . This bioassay has been validated for use with marmoset plasma (Harlow et al, 1984; Hearn et al, 1988 (Sokal and Rohlf, 1981) .
Results

Experiment 1
Each of the three females demonstrated a repeating biphasic cycle for plasma progesterone and the absolute concentrations in each phase reflected those determined by Harlow et al (1983) for the common marmoset. Harlow et al performed laparotomy and demonstrated that progesterone first exceeds 10 ng mlplasma 1 day after ovulation has occurred (day 0). The follicular phase was defined as that period during which progesterone concentration remains below 10 ng ml-1, and the luteal phase as the remaining period of the cycle during which concen¬ trations remain between 10 and 150 ng ml-1 plasma (Harlow et al, 1983) . On the basis of the inter-specific similarity with regard to progesterone profiles, but in the absence of confirm¬ ation of ovulation per se, in this study of Goeldi's monkey the day of ovulation (day 0) is herewith also defined as that preceding the day on which progesterone concentrations first exceeded 10 ng ml-1 (day 1 of the luteal phase). We used this definition to normalize the data obtained for plasma progester¬ one across three to four apparent ovarian cycles from each of the three study females. The average plasma progesterone pro¬ file obtained using this method is presented (Fig. 2a) (Fig. 2b) . The concentrations of urinary pregnanediol-3a-glucuronide (Fig. 2a) and plasma progesterone demonstrated a high, positive correlation across the sampling period (r = 0.80, d.f. = 158, < 0.0001). During the follicular phase, the average urinary concentrations of pregnanediol-3a-glucuronide remained below obtained for oestrone-3-conjugates in plasma and urine from the direct radioimmunoassay are presented (Fig. 2c) . Mean concentrations of oestrone-3-conjugates were low during the inferred follicular phase, except on days -9 to -8; these aver¬ age values included some samples collected at the onset of a 9-10 day follicular phase, and suggest a lag phase in oestrogen secretion and excretion at the end of the progesterone-defined luteal phase of some ovarian cycles. The first significant increase in plasma (F(5,7) = 19.8, < 0.001) and urinary (F(5,9) = 33.5, < 0.001) oestrone-3-conjugates occurred at days 3-4.
Experiment 2
Cloprostenol doses of 10-20 µg kg-1 were necessary for a luteolytic effect to be observed; this represents 8-16 times the dose to which the marmoset is sensitive. In this experiment, we treated each of the three females with two injections of clopros¬ tenol, each consisting of 6.5 µg cloprostenol (taken as equiv¬ alent to 10 µg kg-1) and given 1-2 h apart; this treatment had no visible side effects. Plasma progesterone was measured and used to estimate the day of ovulation as described above; ovulation occurred on day 10, 12 and 13 after cloprostenol injection. The individual profiles that were obtained for pregnanediol-3a-glucuronide and oestrone-3-conjugates in the matching urine samples are shown (Fig. 3) . In the three females, urinary pregnanediol-3a-glucuronide (Fig. 3a) had increased to a luteal-phase' value in excess of 0.20 µg mg-1 creatinine by day 1 or 2 of the inferred luteal phase. In the case of urinary oestrone-3-conjugates, Carroll et al. (1990) defined a concen¬ tration of greater than 5.0 µg urinary oestrone-3-conjugates mg-1 creatinine as being characteristic of the luteal phase. In the present experiment, however, the three females did not secrete more than 5.0 µg mg-1 creatinine until day 4 or 5 ( Fig.   3b) . Follicular values of urinary oestrone-3-conjugates were somewhat reduced in these females relative to those observed in Expt 1 (Fig. 3b versus Fig. 2c ).
Experiment 3
The excretion profiles of pregnanediol-3rz-glucuronide and oestrone-3-conjugates during the sampling period of two of the females from Expt 3 are presented (Fig. 4) . For all inferred ovulations ( = 6), the post-ovulatory increase in the urinary concentration of pregnanediol-3(X-glucuronide to a 'lutealphase' value occurred at least two days before an increase to a 'luteal-phase' value by oestrone-3-conjugates. In some cases, a decrease to a 'follicular-phase' concentration by pregnanediol3a-glucuronide occurred before such a decrease by oestrone-3- conjugates. On the basis of the urinary excretion profiles of pregnanediol-3a-glucuronide for the three females in Expt 3, estimates of the duration of the ovarian cycle of 24, 23 and 24 days were obtained (Fig. 4) . Estimates of individual follicular phases ranged from 8 to 11 days, and of individual luteal phases from 14 to 17 days. The 17-day luteal phase was obtained with a postpartum cycle of the mated female (Fig. 4b) , and it is therefore possible that this was a conception cycle, but with unsuccessful implantation. In general, however, the duration estimates obtained compared favourably with those obtained on the basis of cyclical changes in circulating progesterone in Expt 1 (see Table 2 ). (Bonney et al, 1979) , and the common marmoset Eastman et al, 1984) . The profile of urinary excretion of oestrone-3-conjugates closely reflects that of oestrone-3-conjugates in the circulation, supporting the conclusions of previous studies based on urinary hormones only, that urinary oestrone-3- conjugates are high during the luteal phase (Ziegler et al, 1989 (Ziegler et al, , 1990a Carroll et al, 1990) . Furthermore, studies based on the profiles of reproductive peptides and steroids in the urine of the cotton-top tamarin (Ziegler et al, 1987) , golden-lion tamarin (French et al, 1992) and pygmy marmoset (Ziegler et al, 1990b) , also strongly suggest that oestrogen excretion is high in the luteal phase relative to the follicular phase in clawed New World monkeys. Whereas Carroll et al. (1990) 
